Congress Squares Off With Pharma CEOs In Showdown Over High Drug Prices
Tuesday鈥檚 Senate Finance Committee hearing could produce fireworks over prices, R&D costs and executive compensation.
Drug Costs
401 - 420 of 698 Results
-
-
In Florida, Drug Importation From Canada Finds New Champions, Old Snags
The state鈥檚 governor said the plan has the full support of the White House. But the Trump administration was noncommittal about whether allowing states to buy and import cheaper drugs from up north could be the answer to the nation鈥檚 drug-pricing problem.
By Shefali Luthra and Phil Galewitz -
Video: High Drama No Stranger At Congressional Health Care Hearings
Most hearings before the U.S. House and Senate are routine affairs. But a few tense moments featuring everyone from Hillary Clinton to tobacco CEOs drew the attention of millions of Americans.
By Julie Rovner and Mary Agnes Carey -
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don鈥檛 have to.
-
Talk About D茅j脿 Vu: Senators Set To Re-Enact Drug Price Hearing Of 60 Years Ago
Tuesday鈥檚 Senate hearing with pharma CEOs will tackle the same issues as the famous Kefauver hearings in 1960.
By Jay Hancock -
Today’s Concerns About Drug Prices Echo The Past
Confrontational hearings 60 years ago sparked remarkably similar quotes about drug prices and health care policy.
-
Podcast: KHN鈥檚 鈥榃hat The Health?鈥 How Safe Are Your Supplements?
Alice Ollstein of Politico, Kimberly Leonard of the Washington Examiner and Anna Edney of Bloomberg News join KHN鈥檚 Julie Rovner to discuss the latest national health spending estimates, another FDA crackdown on dietary supplements and lawsuits between insurers and the federal government that could result in a windfall for consumers.
-
The High Cost Of Sex: Insurers Often Don鈥檛 Pay For Drugs To Treat Problems
Medicare and many private insurers view prescribing drugs to improve sexual function as a lifestyle issue that鈥檚 not medically necessary to pay for.
-
Can California Beat The Federal Government In Lowering Drug Prices?
Unwilling to wait for federal action, California Gov. Gavin Newsom says he has a plan that could extract discounts from drugmakers and save the state money 鈥 one he hopes other states can join.
-
Americans Cross Border Into Mexico To Buy Insulin At A Fraction Of U.S. Cost
For one patient, a three-month supply of insulin is $3,700 in the U.S. versus $600 in Mexico. But is it legal?
-
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don鈥檛 have to.
-
Podcast: KHN鈥檚 鈥榃hat The Health?鈥 A 鈥楬ealthy鈥 State Of The Union
Health was a featured player in President Donald Trump鈥檚 2019 State of the Union address. The president set goals to bring down prescription drug prices, end the HIV epidemic in the U.S. and cure childhood cancer, among other things. Margot Sanger-Katz of The New York Times, Anna Edney of Bloomberg News and Alice Ollstein of Politico join KHN鈥檚 Julie Rovner to discuss these issues and, for 鈥渆xtra credit,鈥 provide their favorite health policy stories of the week. Rovner also interviews KHN senior correspondent Phil Galewitz about the current 鈥淏ill of the Month鈥 feature.
-
Trump Administration Salutes Parade Of Generic Drug Approvals, But Hundreds Aren鈥檛 For Sale
President Donald Trump and FDA officials have pointed to a surge in generic drug approvals, but a data analysis indicates almost half haven鈥檛 reached the market.
By Sydney Lupkin and Jay Hancock -
Trump Highlights Health Agenda With Vow To Lower 鈥楿nfair鈥 Drug Prices
The president laid out a series of goals, including lowering prescription prices, pursuing an end to the HIV epidemic and boosting funding for childhood cancers.
By Julie Rovner -
Winners And Losers Under Bold Trump Plan To Slash Drug Rebate Deals
The White House and HHS want to eliminate a 鈥渟hadowy system of kickbacks鈥 in the drug industry pipeline.
By Jay Hancock -
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don鈥檛 have to.
-
Podcast: KHN鈥檚 鈥榃hat The Health?鈥 Live From D.C.: A Look Ahead At Health Policy In 2019
Congress and President Donald Trump are starting to wrestle with health policy issues, and health is already a key debate point in the early run-up to the 2020 Democratic presidential primaries. Might any major health policy legislation be passed and signed this year? Joanne Kenen of Politico, Anna Edney of Bloomberg News and Kimberly Leonard of The Washington Examiner, along with special guest Tom Miller of the American Enterprise Institute, join KHN鈥檚 Julie Rovner to discuss these issues and take questions from a live studio audience.
-
Congress Wades Into Emotional Debate Over High-Cost Prescription Drugs
Key House and Senate committees kick off hearings on drug prices, and patients鈥 families weigh in with tragic stories.
By Emmarie Huetteman and Rachel Bluth -
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don鈥檛 have to.
-
Drug-Pricing Policies Find New Momentum As 鈥楢 2020 Thing鈥
Emboldened by midterm election results and interest in possible presidential runs, Democrats are advancing a slew of new and old legislative proposals. It鈥檚 not yet clear, though, which if any could go the distance.